Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 14, 2005; 11(42): 6671-6675
Published online Nov 14, 2005. doi: 10.3748/wjg.v11.i42.6671
Published online Nov 14, 2005. doi: 10.3748/wjg.v11.i42.6671
Patients | Controls | |
n = 33 | n = 35 | |
Free carnitine (C0) | 27.191 ± 1.194 | 30.029 ± 1.902 |
Short-chain acylcarnitines | ||
Acetylcarnitine (C2) | 4.703 ± 0.205b | 10.227 ± 0.368 |
Propionylcarnitine (C3) | 0.247 ± 0.014b | 0.400 ± 0.021 |
Butyrylcarnitine (C4) | 0.152 ± 0.011b | 0.267 ± 0.013 |
Isovalerylcarnitine (C5) | 0.111 ± 0.010 | 0.138 ± 0.010 |
Tiglylcarnitine (C5:1) | 0.034 ± 0.002 | 0.033 ± 0.003 |
Medium-chain acylcarnitines | ||
Hexanoylcarnitine (C6) | 0.060 ± 0.004b | 0.080 ± 0.006 |
Octanoylcarnitine (C8) | 0.086 ± 0.006b | 0.121 ± 0.009 |
Octenoylcarnitine (C8:1) | 0.037 ± 0.003b | 0.071 ± 0.008 |
Decanoylcarnitine (C10) | 0.103 ± 0.008b | 0.141 ± 0.009 |
Cecenoylcarnitine (C10:1) | 0.063 ± 0.005b | 0.108 ± 0.010 |
Lauroylcarnitine (C12) | 0.032 ± 0.002b | 0.052 ± 0.004 |
Long-chain acylcarnitines | ||
Myristoylcarnitine (C14) | 0.016 ± 0.001b | 0.024 ± 0.001 |
Myristoleylcarnitine (C14:1) | 0.025 ± 0.002b | 0.040 ± 0.004 |
Palmitoylcarnitine (C16) | 0.097 ± 0.006 | 0.113 ± 0.006 |
Palmitoleylcarnitine (C16:1) | 0.037 ± 0.003 | 0.032 ± 0.002 |
Stearoylcarnitine (C18) | 0.076 ± 0.004 | 0.080 ± 0.004 |
Oleylcarnitine (C18:1) | 0.137 ± 0.007b | 0.169 ± 0.008 |
Hydroxymyristoylcarnitine (C14OH) | 0.007 ± 0.001 | 0.005 ± 0.001 |
Hydroxypalmitoylcarnitine (C16OH) | 0.022 ± 0.001 | 0.023 ± 0.002 |
Hydroxypalmitoleylcarnitine (C16:1OH) | 0.026 ± 0.002 | 0.029 ± 0.002 |
Hydroxyoleylcarnitine (C18:1OH) | 0.016 ± 0.002 | 0.013 ± 0.002 |
- Citation: Bene J, Komlósi K, Gasztonyi B, Juhász M, Tulassay Z, Melegh B. Plasma carnitine ester profile in adult celiac disease patients maintained on long-term gluten free diet. World J Gastroenterol 2005; 11(42): 6671-6675
- URL: https://www.wjgnet.com/1007-9327/full/v11/i42/6671.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i42.6671